8 Coupons
-
Special Offer
-
30% off
.
edition
- international editions:
.
- .
- eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
.total digital access /week
he said: "greater and immediate attention needs to be applied in these two areas." .
.
español
.